tezosentan has been researched along with iloprost in 4 studies
Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (iloprost) | Trials (iloprost) | Recent Studies (post-2010) (iloprost) |
---|---|---|---|---|---|
157 | 29 | 33 | 2,150 | 271 | 462 |
Protein | Taxonomy | tezosentan (IC50) | iloprost (IC50) |
---|---|---|---|
Prostacyclin receptor | Homo sapiens (human) | 0.0112 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fischer, V; Geiger, R; Kleinsasser, A; Loeckinger, A; Meier, S; Neu, N; Pajk, W; Stein, JI; Treml, B | 1 |
Albu, G; Beghetti, M; Fontao, F; Habre, W; Janosi, TZ; Petak, F; von Ungern-Sternberg, BS | 1 |
4 other study(ies) available for tezosentan and iloprost
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration.
Topics: Analysis of Variance; Animals; Hemodynamics; Humans; Iloprost; Infant, Newborn; Injections, Intravenous; Meconium Aspiration Syndrome; Pulmonary Gas Exchange; Pyridines; Respiratory Distress Syndrome; Swine; Tetrazoles | 2008 |
Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.
Topics: Administration, Oral; Airway Resistance; Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Hypertension, Pulmonary; Iloprost; Infusion Pumps, Implantable; Infusions, Parenteral; Lung; Lung Volume Measurements; Male; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Prostaglandins I; Purines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Signal Transduction; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors; Vasoactive Intestinal Peptide; Vasodilator Agents | 2011 |